EMA discusses Johnson and Johnson possible link to blood clots


Experts at the agency that regulates drugs for the European union says a warning about very unusual blood clots should be added to labels for Johnson and Johnson's coded nineteen vaccine the European medicines agency says these rare blood disorders should be considered as very rare side effects of the vaccine European officials say they consider the old current available evidence from the U. S. including eight reports of serious cases over red blood clots associated with low blood counts including one death I'm Charles de Ledesma

Coming up next